TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26055847

Group type: EXPERIMENTAL
Intervention: Prenatal hemoglobin concentration measured at first and second ANC visits and at delivery.
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Oral iron, folic acid, and anthelminthics prescribed after the first ANC visit.
Number of subjects: 636
Study: 24634110

Group type: EXPERIMENTAL
Intervention: Lacosamide (200 mg twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Digoxin alone
Number of subjects: 20
Study: 22607870

Group type: EXPERIMENTAL
Intervention: Heparin plus eptifibatide
Number of subjects: 91

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 91
Study: 20854987

Group type: EXPERIMENTAL
Intervention: Synbiotic product containing Lactobacillus gasseri CHO-220 and inulin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 17993025

Group type: EXPERIMENTAL
Intervention: Gutta‐percha with AH 26
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Gutta‐percha with AH Plus
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Resilon with Epiphany
Number of subjects: 70
Study: 15331966

Group type: EXPERIMENTAL
Intervention: Temporal lobectomy for drug-resistant temporo-mesial epilepsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hemispherotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Callosotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple subpial transection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resective surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 0
Study: 11960925

Group type: EXPERIMENTAL
Intervention: Maximal exercise test on a treadmill
Number of subjects: 12
Study: 9794345

Group type: EXPERIMENTAL
Intervention: Precordial actual TENS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Simulated TENS and TENS on the back
Number of subjects: 18

Group type: COMPARATOR
Intervention: TENS (all patients)
Number of subjects: 18
Study: 7623389

Group type: EXPERIMENTAL
Intervention: Matrix outpatient model
Number of subjects: 0
Study: 2651493

Group type: EXPERIMENTAL
Intervention: Zolpidem 5.0 mg and larger doses
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolpidem 7.5 mg and higher doses
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7468415

Group type: EXPERIMENTAL
Intervention: Breathing carbon monoxide (CO) raising COHb from 1.09% to 2.02%
Number of subjects: 15

Group type: COMPARATOR
Intervention: Breathing compressed, purified air lowering COHb from 1.07% to 1.00%
Number of subjects: 15
Study: 31100125

Group type: EXPERIMENTAL
Intervention: Reformed national school feeding program providing 1 hot meal/day in public primary schools
Number of subjects: 2869

Group type: COMPARATOR
Intervention: Control group without intervention
Number of subjects: 2869
Study: 28573779

Group type: EXPERIMENTAL
Intervention: Daily application of skincare (Normaderm®) with fixed combination of adapalene/benzoyl peroxide
Number of subjects: 299

Group type: COMPARATOR
Intervention: Standard emollient alone with fixed combination of adapalene/benzoyl peroxide
Number of subjects: 299
Study: 26399575

Group type: EXPERIMENTAL
Intervention: Usual primary care with the addition of an internet intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet intervention with physiotherapist telephone support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual primary care
Number of subjects: 0
Study: 23356386

Group type: EXPERIMENTAL
Intervention: MBL-HCV1 (50 mg/kg, 11 infusions)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 21304020

Group type: EXPERIMENTAL
Intervention: FET + COT (n = 9)
Number of subjects: 24

Group type: COMPARATOR
Intervention: COT (n = 12)
Number of subjects: 24
Study: 19746439

Group type: EXPERIMENTAL
Intervention: Leukotriene receptor antagonists (LTRAs) in addition to fexofenadine (FEX) for 16 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Acoustic rhinometry at 16 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo in addition to fexofenadine (FEX) for 16 weeks
Number of subjects: 44
Study: 18547587

Group type: EXPERIMENTAL
Intervention: Social anxiety at baseline
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Observation anxieties
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Social interaction anxiety
Number of subjects: 404

Group type: COMPARATOR
Intervention: Controlling for gender, depression, trait anxiety
Number of subjects: 404
Study: 15345796

Group type: EXPERIMENTAL
Intervention: t‐PA therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11774075

Group type: EXPERIMENTAL
Intervention: Intravenous ribavirin treatment
Number of subjects: 140
Study: 9015579

Group type: EXPERIMENTAL
Intervention: Yohimbine (up to 30 mg/day)
Number of subjects: 11
Study: 8235862

Group type: EXPERIMENTAL
Intervention: Electrical stimulation over the lower lumbar paraspinal muscles for 30 minutes twice a day.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified what the control was).
Number of subjects: 40
Study: 3469601

Group type: EXPERIMENTAL
Intervention: Alcoholic benzydamine hydrochloride
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Aqueous chlorhexidine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Benzydamine-free placebo mouthwash
Number of subjects: 18
Study: 11237234

Group type: EXPERIMENTAL
Intervention: MDI with home-made spacer (10 puffs of salbutamol, 100 microg/puff)
Number of subjects: 60

Group type: COMPARATOR
Intervention: MDI with commercial spacer (10 puffs of salbutamol, 100 microg/puff)
Number of subjects: 60
Study: 31331352

Group type: EXPERIMENTAL
Intervention: Anterolateral approach
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lateral approach
Number of subjects: 26
Study: 28643069

Group type: EXPERIMENTAL
Intervention: Laparoscopic HIPEC with Mitomycin C 30 mg and Cisplatin 200 mg in 3-7 L of infusate for 60 min, performed up to five times.
Number of subjects: 19
Study: 26778759

Group type: EXPERIMENTAL
Intervention: E-cigarette with 23.5% alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: E-cigarette with 0.4% alcohol (trace)
Number of subjects: 0
Study: 25453458

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 2876
Study: 22678178

Group type: EXPERIMENTAL
Intervention: Conventional, uncrossed manipulation system (UCMS) with straight instruments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Conventional, uncrossed manipulation system (UCMS) with curved instruments
Number of subjects: 18

Group type: COMPARATOR
Intervention: Crossed manipulation system (CMS) with curved instruments
Number of subjects: 18
Study: 19942485

Group type: EXPERIMENTAL
Intervention: ALV003 pre-treated gluten (16 g daily for 3 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo pre-treated gluten (16 g daily for 3 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ALV003 pre-treated gluten
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo pre-treated gluten
Number of subjects: 20
Study: 17511533

Group type: EXPERIMENTAL
Intervention: Cognitive treatment group (n=16)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control treatment group (n=26)
Number of subjects: 42
Study: 16108935

Group type: EXPERIMENTAL
Intervention: Intense tai chi exercise program
Number of subjects: 311

Group type: COMPARATOR
Intervention: Wellness education (WE) program
Number of subjects: 311
Study: 11953285

Group type: EXPERIMENTAL
Intervention: Music therapy (Group B)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Conventional procedure (Group A)
Number of subjects: 146
Study: 10364647

Group type: EXPERIMENTAL
Intervention: Tacrine 30 mg/day for 6 weeks, 60 mg/day for 6 weeks, 90 mg/day for 6 weeks, 120 mg/day for 12 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tacrine (active group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 100
Study: 7562109

Group type: EXPERIMENTAL
Intervention: 200 micrograms/d of total folate
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 300 micrograms/d of total folate
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 400 micrograms/d of total folate
Number of subjects: 17
Study: 2389073

Group type: EXPERIMENTAL
Intervention: 1.2% isoflurane (group A)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 13
Study: 6906160

Group type: EXPERIMENTAL
Intervention: timolol (0.1%) and dipivalyl-epinephrine (0.25%)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: timolol (0.25%) and dipivalyl-epinephrine (0.1%)
Number of subjects: 27

Group type: COMPARATOR
Intervention: timolol (0.25%) bis x
Number of subjects: 27
Study: 31265113

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 6.4 g/kg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 7.2 g/kg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 8.0 g/kg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 8.8 g/kg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 9.6 g/kg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 10.4 g/kg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Dietary lysine level of 8.6 g/kg
Number of subjects: 540
Study: 27400922

Group type: EXPERIMENTAL
Intervention: Case Management (CM) intervention consisting of assistance in obtaining income entitlements, referral to primary or specialty medical care, access to mental health care or substance abuse treatment, and counseling on at-risk behaviors and health care utilization.
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard emergency care (control group).
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Case Management (CM) intervention.
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Poor social determinants of health (predictor variable).
Number of subjects: 250
Study: 24326412

Group type: EXPERIMENTAL
Intervention: Internal medicine/endocrinology practice
Number of subjects: 168

Group type: COMPARATOR
Intervention: Family practice clinic
Number of subjects: 168
Study: 24705855

Group type: EXPERIMENTAL
Intervention: E‐MOSAIC (PALM version)
Number of subjects: 62

Group type: COMPARATOR
Intervention: E‐MOSAIC (paper version)
Number of subjects: 62
Study: 23265031

Group type: EXPERIMENTAL
Intervention: Analgesia with remifentanil
Number of subjects: 58

Group type: COMPARATOR
Intervention: Anesthesia with propofol and alfentanil
Number of subjects: 58
Study: 19544097

Group type: EXPERIMENTAL
Intervention: Cefditoren
Number of subjects: 4582

Group type: COMPARATOR
Intervention: Comparators
Number of subjects: 4582
Study: 17726084

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15831772

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (inhaled corticosteroids, 2 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (oral corticosteroids, 50 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 18
Study: 11691516

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen, 0.625 mg/day for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10205349

Group type: EXPERIMENTAL
Intervention: gamma-linolenic and eicosapentaenoic acids
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study: 7933039

Group type: EXPERIMENTAL
Intervention: Continuous wave Doppler examination
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Standard duplex scanning
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Color Doppler flow imaging
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ultrasonic methods (continuous wave Doppler combined with color Doppler flow imaging)
Number of subjects: 42
Study: 3280614

Group type: EXPERIMENTAL
Intervention: Dilazep (0.2 mg/kg body weight by IV infusion for ten minutes)
Number of subjects: 12
Study: 31720819

Group type: EXPERIMENTAL
Intervention: Aspirin or cilostazol treatment with best medical therapy
Number of subjects: 1240
Study: 29318443

Group type: EXPERIMENTAL
Intervention: Push intervention components of mHealth interventions (e.g., notifications or text messages)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HeartSteps mHealth intervention
Number of subjects: 0
Study: 29165753

Group type: COMPARATOR
Intervention: Intravenous injection of 0.5 μg/kg remifentanil (Control group)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Atomization inhalation of 15 mg ambroxol hydrochloride and 0.5 mg budesonide suspension (Observation group)
Number of subjects: 46
Study: 25831405

Group type: EXPERIMENTAL
Intervention: H2N2 live attenuated influenza vaccine (LAIV)
Number of subjects: 0
Study: 22633044

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stenting (CAS)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cerebral protection device (CPD) used in treatment
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Open- and closed-cell stents
Number of subjects: 55
Study: 20932523

Group type: EXPERIMENTAL
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Proximal Femoral Nail (PFN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both DHS and PFN
Number of subjects: 20
Study: 19335077

Group type: EXPERIMENTAL
Intervention: Ultrasonic piezoelectric devices
Number of subjects: 11

Group type: COMPARATOR
Intervention: Curets (Control)
Number of subjects: 11
Study: 16430773

Group type: EXPERIMENTAL
Intervention: Individualized BMD feedback with low BMD
Number of subjects: 470

Group type: COMPARATOR
Intervention: Osteoporosis information leaflet
Number of subjects: 470

Group type: COMPARATOR
Intervention: Osteoporosis self-management course
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Starting calcium supplements
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Persistent self-reported change in physical activity levels
Number of subjects: 470
Study: 15574614

Group type: EXPERIMENTAL
Intervention: Nurse home visits
Number of subjects: 743

Group type: COMPARATOR
Intervention: Comparison services
Number of subjects: 743
Study: 11018197

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug treatment
Number of subjects: 264
Study: 8774298

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Pericervical insemination
Number of subjects: 88
Study: 1466432

Group type: EXPERIMENTAL
Intervention: Fentanyl/propofol anaesthesia (propofol infusion 6 mg.kg‐1.h‐1, reduced after 10 min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fentanyl/enflurane anaesthesia (enflurane 0.8% inspired concentration, reduced to 0.6%)
Number of subjects: 20
Study: 6230648

Group type: EXPERIMENTAL
Intervention: Mezlocillin (2 g dose administered intravenously 1 hour before surgery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no mezlocillin)
Number of subjects: 100
Study: 30693399

Group type: EXPERIMENTAL
Intervention: Immediate implant placement + deproteinized bovine bone derived with collagen
Number of subjects: 22

Group type: COMPARATOR
Intervention: Immediate implant placement without biomaterial
Number of subjects: 22
Study: 28375891

Group type: EXPERIMENTAL
Intervention: Bridge plate osteosynthesis
Number of subjects: 110

Group type: COMPARATOR
Intervention: Functional brace
Number of subjects: 110
Study: 26500463

Group type: EXPERIMENTAL
Intervention: Zeolite supplementation (1.85 g per day for 12 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 52
Study: 23917308

Group type: EXPERIMENTAL
Intervention: Resistance exercise program (12 weeks, based on location of bone lesions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study: 21552183

Group type: EXPERIMENTAL
Intervention: 5 μg mpHBV
Number of subjects: 1718

Group type: EXPERIMENTAL
Intervention: 10 μg mpHBV
Number of subjects: 1718

Group type: COMPARATOR
Intervention: Recombivax‐HB (5 μg)
Number of subjects: 1718

Group type: COMPARATOR
Intervention: Engerix‐B (10 μg)
Number of subjects: 1718
Study: 19843809

Group type: EXPERIMENTAL
Intervention: 8 mg oral ondansetron the evening before surgery plus IV 8 mg ondansetron 15 min before subarachnoid anesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 17185094

Group type: COMPARATOR
Intervention: Standard video colonoscope (Method A)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Colonoscope with retrograde-viewing auxiliary device (Method B)
Number of subjects: 6
Study: 15465140

Group type: EXPERIMENTAL
Intervention: 3D conformal radiotherapy (66 Gy)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Conventional radiotherapy (66 Gy)
Number of subjects: 266
Study: 11906340

Group type: EXPERIMENTAL
Intervention: Synthetic quilt use
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Increasing synthetic upper bedding use
Number of subjects: 758
Study: 10088569

Group type: EXPERIMENTAL
Intervention: rhGH, 0.2 mg/kg per day intramuscularly (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 20
Study: 7502702

Group type: EXPERIMENTAL
Intervention: Calcium (1 g of calcium)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1953991

Group type: EXPERIMENTAL
Intervention: Alcohol (0.75 g/kg body weight in 500 ml carbon dioxide‐free mineral water)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (1,000 mg powdered, average 13.1 mg/kg body weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alcohol and acetylsalicylic acid combination
Number of subjects: 12
Study: 7008940

Group type: EXPERIMENTAL
Intervention: Rociverine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Butylscopolamine bromide
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 300
Study: 6091382

Group type: EXPERIMENTAL
Intervention: Dexon (absorbable polyglycolic acid)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Mersilene
Number of subjects: 520
Study: 28831814

Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting group programme
Number of subjects: 545
Study: 26827999

Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Chamomilla recutita
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 24755382

Group type: EXPERIMENTAL
Intervention: Inspiron (sirolimus-eluting stent with abluminal biodegradable polymer)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cronus (stent without polymer coating or drug elution)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Inspiron
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cronus
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 22762317

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (≥800 IU daily)
Number of subjects: 31022

Group type: COMPARATOR
Intervention: Vitamin D supplementation (unspecified dosage)
Number of subjects: 31022
Study: 20531072

Group type: EXPERIMENTAL
Intervention: Coaptive film (Steri Strip S; 3 M company)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Subcuticular Monocryl sutures (3-0)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Coaptive film
Number of subjects: 25

Group type: COMPARATOR
Intervention: Subcuticular Monocryl sutures
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Coaptive film and Subcuticular Monocryl sutures
Number of subjects: 25
Study: 18784223

Group type: EXPERIMENTAL
Intervention: Praziquantel (40 mg/kg) at baseline
Number of subjects: 378

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 378
Study: 15916656

Group type: EXPERIMENTAL
Intervention: Misoprostol (50 microg perivaginally)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dinoprostone gel (0.5 mg intracervically)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN) (0.5 mg perivaginally)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Misoprostol (50 microg perivaginally) in severely unfavorable cervix (Bishop score ≤3)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dinoprostone gel (0.5 mg intracervically) in severely unfavorable cervix (Bishop score ≤3)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN) (0.5 mg perivaginally) in severely unfavorable cervix (Bishop score ≤3)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dinoprostone
Number of subjects: 65

Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 65
Study: 12643609

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg at night
Number of subjects: 60

Group type: COMPARATOR
Intervention: pantoprazole 40 mg in the morning
Number of subjects: 60
Study: 15613189

Group type: EXPERIMENTAL
Intervention: Weekend headache in patients with migraine without aura
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Weekend headache in patients with episodic tension-type headache
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Clinical features of weekend headache
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Triggering factors for weekend headache
Number of subjects: 240
Study: 8701408

Group type: EXPERIMENTAL
Intervention: APC resistance test using Coatest APC Resistance
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: APC resistance test
Number of subjects: 393
Study: 2066747

Group type: EXPERIMENTAL
Intervention: Funded communities (intervention group)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Unfunded comparison groups (control group)
Number of subjects: 11
Study: 6405584

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (15 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 80
Study: 31142336

Group type: EXPERIMENTAL
Intervention: One-day training in trauma inquiry ('Learning How to Ask') plus a refresher session 3 months later
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 148